Welcome

Please select your view

Assoc. Prof. Mirette Saad

Qualification: MBBS (Hons), MD, MAACB, FRCPA, PhD.
Lab: Clayton
Areas Of Interest: Molecular Genetics, Precision Medicine, Cancer Genetics, Antenatal Screening, NIPT, Endocrine, Fertility Testing and Research, Medical Teaching
Speciality: Chemical Pathology,Molecular Biology

Phone: 03 9538 6777
Email: Mirette.Saad@clinicallabs.com.au


Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Clinical Director of Molecular Genetic Pathology at Australian Clinical Labs. Associate Professor Saad graduated with honours in Medicine from Suez Canal University in Egypt. She obtained her Speciality Fellowship in Chemical and Molecular Pathology with a Microbiology sub-speciality following training at Suez Canal University Hospitals. After several posts, she worked as a Medical Laboratory Director in private labs and as an Associate Professor and Examiner of Clinical Chemistry for postgraduate and undergraduate medical and nursing students at various institutions. Upon receiving the National Health and Medical Research (NHMRC) Scholarship in 2006, Associate Professor Saad commenced her PhD studies at Melbourne University and Peter MacCallum Cancer Institute in Cancer Genetics. Associate Professor Saad is a Registered Medical Practitioner with AHPRA and is actively involved in clinical teaching at the Australian Medical Council (AMC) and Melbourne University. Associate Professor Saad undertook her speciality training at Healthscope Pathology (now Australian Clinical Labs) and Monash Health and obtained the Chemical Pathology Fellowship (FRCPA) and the Membership (MAACB) by examination from the Royal College of Pathologists of Australasia (RCPA) and the Australasian Association of Clinical Biochemists (AACB) respectively. She is currently a member of the Chemical Pathology Advisory Committee at RCPA. Associate Professor Saad’s PhD research allowed her to gain unique experience in a wide range of biochemical, molecular genetics and cancer targeting; having published several articles both locally and internationally. At Clinical Labs, Associate Professor Saad supervises the antenatal screening program including combined First Trimester Screening and Non-Invasive Prenatal Testing (NIPT) along with the Molecular Genetic testing for hereditary disorders, personalised drug therapy and cancer. She is Chair of Precision Medicine Services at Australian Clinical Labs.